Cultivated Meat Hits a Regulatory Wall in the U.S. as Australia Opens Retail Sales and Eight States Enforce Bans
The Eleventh Circuit upholds Florida's cultivated meat ban as Australia launches consumer retail, splitting the global market between expansion and prohibition.
Overview
The cultivated meat industry entered April 2026 facing a widening divide between jurisdictions racing to commercialize cell-cultured proteins and those moving to prohibit them outright. In the United States, the Eleventh Circuit Court of Appeals upheld Florida’s ban on cultivated meat on March 23, ruling that the state law does not conflict with federal poultry inspection statutes. Meanwhile, Australia became the latest country to move cultivated meat from laboratory curiosity to consumer product, with startup Vow launching direct-to-consumer retail sales of cultured quail products under its Forged brand.
The simultaneous expansion and restriction of cultivated meat reflects a global regulatory landscape that remains deeply fragmented, even as the market is projected to grow from $43.27 million in 2026 to $114.51 million by 2031, according to Mordor Intelligence.
The Eleventh Circuit Ruling
In Upside Foods, Inc. v. Commissioner, Florida Department of Agriculture and Consumer Services (No. 24-13640), a unanimous three-judge panel rejected the California-based cultivated chicken company’s argument that Florida’s Senate Bill 1084 is preempted by the federal Poultry Products Inspection Act. Judge Andrew Brasher wrote that “Florida’s ban on lab-grown meat does not regulate Upside’s ingredients, premises, facilities, or operations” and therefore federal law does not preempt the state statute.
The court drew a distinction between state laws that dictate how federally inspected facilities operate, which the PPIA does preempt, and outright product bans, which it does not. The ruling aligns with precedent from the Fifth, Seventh, and Ninth Circuits, which have upheld state bans on horsemeat and foie gras on similar grounds.
Florida enacted SB 1084 in July 2024, criminalizing the manufacture, sale, and distribution of cultivated meat. Since then, seven additional states have imposed restrictions. Alabama, Mississippi, Montana, and Nebraska have passed permanent bans. Texas signed SB 261 into law in June 2025, imposing a two-year prohibition, and Indiana enacted a similar two-year ban effective July 2025. South Dakota Governor Larry Rhoden signed a five-year moratorium on March 11, 2026, after vetoing an earlier permanent ban proposal.
Australia Opens Retail Sales
While American states moved to restrict cultivated meat, Australia embraced it. Food Standards Australia New Zealand granted final approval to Vow Group’s cultured Japanese quail in June 2025 under Application A1269, concluding that the product presents no toxicological, nutritional, or allergenic concerns. FSANZ simultaneously established new standards requiring products to carry “cell-cultured” or “cell-cultivated” labeling.
Vow has since launched three consumer products under its Forged brand: a smoked quail spread, a foie gras product, and frozen croquettes, available for home delivery in the Greater Sydney region. The company reports 200 percent month-over-month demand growth in Singapore, where it also holds approval. Vow is the only cultivated meat startup approved in three jurisdictions: Singapore, Australia, and New Zealand.
The U.S. Approval Landscape
The federal regulatory picture in the United States remains favorable for the technology even as state-level opposition intensifies. The FDA has completed pre-market consultations and issued “no questions” letters to five companies: Upside Foods and Good Meat for chicken, Wildtype for salmon, Mission Barns for pork fat, and Believer Meats for poultry. Mission Barns achieved a notable milestone when its Italian-style cultivated pork meatballs became the first cultivated meat product sold at retail in the United States.
However, the path from regulatory clearance to commercial viability has proven treacherous. Believer Meats, an Israeli company that completed a $34 million production facility in Wilson, North Carolina, the world’s largest dedicated cultivated meat plant, ceased operations in December 2025 without ever beginning commercial production. The facility had a projected annual capacity of 12,000 metric tons but faced unresolved equipment issues and failed to secure emergency funding.
What We Don’t Know
Several critical questions remain unanswered. Upside Foods’ case continues in district court despite losing the preliminary injunction, and the company may seek rehearing or petition the Supreme Court. Whether additional states will follow the current wave of bans is uncertain, with bills pending in Arizona, Georgia, and Louisiana.
The economics of cultivated meat at scale remain unproven. The growth medium needed to feed animal cells can cost hundreds to thousands of dollars per liter, according to TechCrunch, and venture capital interest has shifted toward artificial intelligence, leaving cultivated meat startups struggling for funding.
Research into cost reduction continues. A team at University College London published findings in Frontiers in Nutrition demonstrating that spent yeast from beer fermentation can be repurposed into bacterial cellulose scaffolds for animal cell growth, potentially offering a cheaper alternative to conventional production methods, as reported by Phys.org.
Analysis
The Eleventh Circuit ruling represents more than a single state’s policy preference. By establishing that product bans fall outside federal preemption, the court has given states a durable legal framework for restricting cultivated meat regardless of federal approval. The practical effect is the emergence of a patchwork market where a product cleared by both the FDA and USDA can nonetheless be criminal to sell depending on geography.
For the cultivated meat industry, the challenge is no longer primarily scientific or regulatory at the federal level. It is commercial, financial, and increasingly political. The collapse of Believer Meats, despite holding both FDA and USDA approval and owning a completed production facility, illustrates that regulatory clearance alone cannot sustain a business that has not yet achieved cost-competitive production.